KIRO Oncology
Robotic Compounding System for sterile preparations of hazardous drugs
KIRO Oncology helps to protect health care workers from the potential risks associated with manual drug admixture, especially from exposure to hazardous drugs. Additionally, the fully automated process optimizes the drug preparation output of the Hospital Pharmacy and enables digital control and tracing of complex workflows to help reducing medication errors. The benefits of B. Braun Safe Infusion Systems, combined with Kiro Grifols Automated Compounding Portfolio offer a complete solution for safe automated drug admixture and delivery.
Advantages
Patient Safety
- Precision scales of KIRO Oncology offer gravimetric verification at all stages of the compounding process to control dosing accuracy
- In-process barcode readers and cameras allow the identification of drugs, disposables, and final containers to document traceability
Staff Protection
- KIRO Oncology self-cleaning process protects operators from potential exposure to hazardous chemicals by avoiding manual cleaning of the device
- Its integrated system allows the automatic disposal of hazardous waste into self-contained bags
- Operators are protected from repetitive stress injuries potentially occurring during manual compounding
Flexibility and Efficiency
- KIRO Oncology supports a wide range of B. Braun Infusion Therapy products such as the IV container Ecoflac® plus, Cyto-Set® IV administration sets, and Protective Admixture Tools.
- Prepares patient-specific doses and small batches using liquid or lyophilized drugs
- Offers increased user efficiency by allowing identification and labeling of materials by the user during automatic compounding
- Offers configuration options to respond to specific compounding practices, workflows, and clinical needs